144 related articles for article (PubMed ID: 32488110)
1. UPLC-Tandem Mass Spectrometry for Quantification of Busulfan in Human Plasma: Application to Therapeutic Drug Monitoring.
Matar KM; Alshemmari SH; Refaat S; Anwar A
Sci Rep; 2020 Jun; 10(1):8913. PubMed ID: 32488110
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance.
Choong E; Uppugunduri CRS; Marino D; Kuntzinger M; Doffey-Lazeyras F; Lo Piccolo R; Chalandon Y; Peters C; Daali Y; Ansari M
Ther Drug Monit; 2018 Feb; 40(1):84-92. PubMed ID: 29189665
[TBL] [Abstract][Full Text] [Related]
3. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation.
Ansari M; Théoret Y; Rezgui MA; Peters C; Mezziani S; Desjean C; Vachon MF; Champagne MA; Duval M; Krajinovic M; Bittencourt H;
Ther Drug Monit; 2014 Feb; 36(1):93-9. PubMed ID: 24061446
[TBL] [Abstract][Full Text] [Related]
4. Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies.
Tran HT; Madden T; Petropoulos D; Worth LL; Felix EA; Sprigg-Saenz HA; Choroszy M; Danielson M; Przepiorka D; Chan KW
Bone Marrow Transplant; 2000 Sep; 26(5):463-70. PubMed ID: 11019834
[TBL] [Abstract][Full Text] [Related]
5. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry.
Ansari M; Uppugunduri CR; Déglon J; Théorêt Y; Versace F; Gumy-Pause F; Ozsahin H; Dayer P; Desmules J; Daali Y
Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1437-46. PubMed ID: 22592987
[TBL] [Abstract][Full Text] [Related]
6. A rapid and simple LC-MS/MS method for personalized busulfan dosing in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT).
Xiao Y; Li X; Fu X
Clin Chim Acta; 2018 Apr; 479():190-195. PubMed ID: 29341904
[TBL] [Abstract][Full Text] [Related]
7. A rapid HPLC-MS/MS method for determining busulfan in hemolytic samples from children with hematopoietic stem cell transplantation.
Jinjie Y; Sun N; Zhang S; Feng X; Chen X; Zhao D; Zhao L
Biomed Chromatogr; 2020 Sep; 34(9):e4898. PubMed ID: 32428257
[TBL] [Abstract][Full Text] [Related]
8. A rapid & sensitive liquid chromatography- tandem mass spectrometry method for the quantitation of busulfan levels in plasma & application for routine therapeutic monitoring in haematopoietic stem cell transplantation.
Desire S; Mohanan EP; George B; Mathews V; Chandy M; Srivastava A; Balasubramanian P
Indian J Med Res; 2013 Apr; 137(4):777-84. PubMed ID: 23703347
[TBL] [Abstract][Full Text] [Related]
9. Use of an Oral Busulfan Test Dose in Patients Undergoing Hematopoietic Stem Cell Transplantation Treated With or Without Fludarabine.
de Castro FA; Simões BP; Godoy AL; Bertagnoli Trigo FM; Coelho EB; Lanchote VL
J Clin Pharmacol; 2016 Dec; 56(12):1555-1562. PubMed ID: 27130252
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study.
Jansing T; Sanpakit K; Tharnpanich T; Jiranantakan T; Niphandwongkorn V; Chindavijak B; Suansanae T
Pediatr Hematol Oncol; 2021 May; 38(4):346-357. PubMed ID: 33656974
[TBL] [Abstract][Full Text] [Related]
11. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children.
Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M
Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116
[TBL] [Abstract][Full Text] [Related]
12. Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children : validation of liquid chromatography tandem mass spectrometry method.
Rauh M; Stachel D; Kuhlen M; Gröschl M; Holter W; Rascher W
Clin Pharmacokinet; 2006; 45(3):305-16. PubMed ID: 16509762
[TBL] [Abstract][Full Text] [Related]
13. Tandem mass spectrometry method for the quantification of serum busulfan.
Kellogg MD; Law T; Sakamoto M; Rifai N
Ther Drug Monit; 2005 Oct; 27(5):625-9. PubMed ID: 16175136
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Two Analytical Methods for Busulfan Therapeutic Drug Monitoring.
De Gregori S; Tinelli C; Manzoni F; Bartoli A
Eur J Drug Metab Pharmacokinet; 2021 Jan; 46(1):155-159. PubMed ID: 33231835
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC-MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning.
Punt AM; Langenhorst JB; Egas AC; Boelens JJ; van Kesteren C; van Maarseveen EM
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1055-1056():81-85. PubMed ID: 28445850
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of busulfan in transplantation.
Russell JA; Kangarloo SB
Curr Pharm Des; 2008; 14(20):1936-49. PubMed ID: 18691105
[TBL] [Abstract][Full Text] [Related]
17. Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry. Application to pharmacokinetic studies in children.
Quernin MH; Duval M; Litalien C; Vilmer E; Aigrain EJ
J Chromatogr B Biomed Sci Appl; 2001 Nov; 763(1-2):61-9. PubMed ID: 11710584
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Busulfan in Plasma by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Pablo A; Breaud AR; Clarke W
Curr Protoc Toxicol; 2020 Jun; 84(1):e93. PubMed ID: 32469450
[TBL] [Abstract][Full Text] [Related]
19. Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy.
Lindley C; Shea T; McCune J; Shord S; Decker J; Harvey D; Petros WP; Garbriel D; Serody J; Kirby S; Wiley J
Anticancer Drugs; 2004 Jun; 15(5):453-9. PubMed ID: 15166618
[TBL] [Abstract][Full Text] [Related]
20. A novel method for quantification of sulfolane (a metabolite of busulfan) in plasma by gas chromatography-tandem mass spectrometry.
Versace F; Uppugunduri CR; Krajinovic M; Théorêt Y; Gumy-Pause F; Mangin P; Staub C; Ansari M
Anal Bioanal Chem; 2012 Oct; 404(6-7):1831-8. PubMed ID: 22918536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
